These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9385487)

  • 1. Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males.
    Kosoglou T; Radwanski E; Batra VK; Lim JM; Christopher D; Affrime MB
    Clin Ther; 1997; 19(5):1002-12. PubMed ID: 9385487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of food on the oral bioavailability of loratadine and pseudoephedrine from extended-release tablets in healthy volunteers.
    Nomeir AA; Mojaverian P; Kosoglou T; Affrime MB; Nezamis J; Rodwanski E; Lin CC; Cayen MN
    J Clin Pharmacol; 1996 Oct; 36(10):923-30. PubMed ID: 8930779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults.
    Howard DR; Haribhakti R; Kittner B; Agrawala P
    Curr Med Res Opin; 2005 May; 21(5):769-76. PubMed ID: 15969876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic properties of single-dose loratadine and ambroxol alone and combined in tablet formulations in healthy men.
    Villacampa J; Alcántar F; Rodríguez JM; Morales JM; Herrera J; Rosete R
    Clin Ther; 2003 Aug; 25(8):2225-32. PubMed ID: 14512130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis.
    Kaiser HB; Banov CH; Berkowitz RR; Bernstein DI; Bronsky EA; Georgitis JW; Mendelson LM; Rooklin AR; Sholler LJ; Stricker WW; Harrison JE; Danzig MR; Lorber RR
    Am J Ther; 1998 Jul; 5(4):245-51. PubMed ID: 10099066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the side effects between pseudoephedrine in Loratadine plus Pseudoephedrine Sulfate Repetabs Tables and loratadine + pseudoephedrine tablet in treatment of allergic rhinitis in Thai patients.
    Supiyaphun P; Chochaipanichnon L; Kerekhanjanarong V; Saengpanich S
    J Med Assoc Thai; 2002 Jun; 85(6):722-7. PubMed ID: 12322847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis.
    Bronsky E; Boggs P; Findlay S; Gawchik S; Georgitis J; Mansmann H; Sholler L; Wolfe J; Meltzer E; Morris R
    J Allergy Clin Immunol; 1995 Aug; 96(2):139-47. PubMed ID: 7636050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis.
    Storms WW; Bodman SF; Nathan RA; Chervinsky P; Banov CH; Dockhorn RJ; Jarmoszuk I; Zeitz HJ; McGeady SJ; Pinnas JL
    J Allergy Clin Immunol; 1989 Jun; 83(6):1083-90. PubMed ID: 2471718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine.
    Kosoglou T; Salfi M; Lim JM; Batra VK; Cayen MN; Affrime MB
    Br J Clin Pharmacol; 2000 Dec; 50(6):581-9. PubMed ID: 11136297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of modified-release dosage forms containing loratadine and pseudoephedrine sulfate.
    Sznitowska M; Cal K; Kupiec K
    Acta Pol Pharm; 2004 Dec; 61 Suppl():72-4. PubMed ID: 15909946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study.
    Gupta S; Banfield C; Kantesaria B; Marino M; Clement R; Affrime M; Batra V
    Clin Ther; 2001 Mar; 23(3):451-66. PubMed ID: 11318079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion.
    Schenkel E; Corren J; Murray JJ
    Allergy Asthma Proc; 2002; 23(5):325-30. PubMed ID: 12476542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
    Timmins P; Donahue S; Meeker J; Marathe P
    Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.
    Noehr-Jensen L; Damkier P; Bidstrup TB; Pedersen RS; Nielsen F; Brosen K
    Eur J Clin Pharmacol; 2006 Jun; 62(6):437-45. PubMed ID: 16770647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and Pharmacodynamics of Twice Daily and Once Daily Regimens of Empagliflozin in Healthy Subjects.
    Macha S; Brand T; Meinicke T; Link J; Broedl UC
    Clin Ther; 2015 Aug; 37(8):1789-96. PubMed ID: 26138865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.